Teleflex Incorporated (TFX) Stock Score, Valuation & Financial Research
Teleflex Incorporated is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 16/100.
Quick answer for TFX
Teleflex Incorporated currently has a Wall Street Score of 16/100. The stored market price is $128. Its financial score is 5/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Teleflex Incorporated does
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interve
TFX financial snapshot
- Wall Street Score:
- 16/100
- Current price:
- $128
- Market capitalization:
- $5.67B
- Revenue:
- $2.81B
- Net income:
- $-1.01B
- Free cash flow:
- $245.4M
- Cash:
- $309.4M
- Total debt:
- $2.69B
- EPS:
- -20.30
- Financial score:
- 5/100
- Valuation score:
- 0/100
- Revenue score:
- 25/100
What stands out
- Reported year-over-year revenue growth is +0.4%.
- Free cash flow is $245.4M, showing positive cash generation.
- The balance sheet shows $309.4M of cash versus $2.69B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 5/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research TFX
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.